dimyristoylphosphatidylglycerol has been researched along with Candidiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fainstein, V; Hersh, EM; Hopfer, RL; Juliano, R; Kasi, L; Lopez-Berestein, G; Luna, M; Mehta, K; Mehta, R; Mills, K | 1 |
| Bonner, DP; Clark, JM; George, RJ; Kunselman, L; Olsen, SJ; Swerdel, MR; Whitney, RR | 1 |
2 other study(ies) available for dimyristoylphosphatidylglycerol and Candidiasis
| Article | Year |
|---|---|
Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B.
Topics: Amphotericin B; Animals; Candidiasis; Dimyristoylphosphatidylcholine; Liposomes; Mice; Phosphatidylcholines; Phosphatidylglycerols | 1983 |
Amphotericin B lipid complex therapy of experimental fungal infections in mice.
Topics: Amphotericin B; Animals; Aspergillosis; Candidiasis; Cryptococcosis; Dimyristoylphosphatidylcholine; Excipients; Female; Histoplasmosis; Liposomes; Mice; Mycoses; Phosphatidylglycerols | 1991 |